PRME Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own PRME shares is 169, representing 62.4% of the company's common stock.

N/A, in the last quarter, reduced its stake in PRME by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the PRME shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned PRME shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, N/A increased its stake in PRME by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of PRME to its portfolio, raising its holding to - shares of worth -. N/A also increased its PRME shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in PRME is Cahill Thomas , director at the company. Additionally, PRME stock is highly held by NELSEN ROBERT and 10 percent owner ARCH Venture Partners XII, LLC among others.

Company executives, directors, and other insiders own 23.91% percent of Prime Medicine, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which PRME insiders have sold stock, totaling 0 shares. Insiders that have sold shares include GV 2019 GP, L.L.C..

There have been 0 transaction(s) during the past 6-months in which Prime Medicine, Inc. insiders have bought stock, totalling 0 shares

Around 0 Prime Medicine, Inc. shares are held by insiders, which represents about 23.91% of PRME stock.

PRME director, Cahill Thomas holds the largest portfolio of the company's shares. PRME shares owned by Cahill total nearly 5.31 million.

N/A is the largest institutional owner in PRME which holds - shares worth - or N/A of the total PRME shares outstanding followed by N/A with ownership of - shares representing N/A of the PRME ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the PRME is concerned, it is a stock which is optionable.

Number of PRME shares short is 17.21M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 131.16M shares of PRME are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, PRME has 60.42M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for PRME is 15.18.